Guided Therapeutics, Inc. (GTHP)
| Market Cap | 14.48M -30.7% |
| Revenue (ttm) | 650.00K +450.8% |
| Net Income | -3.64M |
| EPS | -0.04 |
| Shares Out | 96.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,730 |
| Open | 0.2318 |
| Previous Close | 0.1900 |
| Day's Range | 0.1500 - 0.2318 |
| 52-Week Range | 0.1373 - 0.5400 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therap... [Read more]
Financial Performance
In 2025, Guided Therapeutics's revenue was $767,000, an increase of 10857.14% compared to the previous year's $7,000. Losses were -$3.35 million, 29.1% more than in 2024.
Financial StatementsNews
Guided Therapeutics reaches collaborative agreement with Turkiye MOH
Guided Therapeutics (GTHP) announced that it has reached an agreement with the Ministry of Health, MOH, to co-develop LuViva for primary screening of cervical cancer in Turkiye. The first step…
Guided receives $80,000 payment as fourth installment of purchase order
Guided Therapeutics (GTHP) announced that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company. The payment is the fourth installment of a $700,000...
Guided Therapeutics enters new agreement with Yuanshuo Medical Instruments
Guided Therapeutics (GTHP) reached a new agreement with Yuanshuo Medical Instruments Corporation to supply them with LuViva instruments, single-use components and support services. YMIC is headquarter...
Guided Therapeutics files PMA application clinical report with FDA
Guided Therapeutics (GTHP) filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration. The study protocol was developed through interactions with FDA and enrolled 4...
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba...
Guided Therapeutics says preliminary analysis of FDA study data completed
Guided Therapeutics (GTHP) provided several updates in conjunction with the Company’s 2025 10k financial report, filed on March 30. First, preliminary analysis of the FDA clinical study data has been…
Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba...
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba...
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $88,000 from distrib...
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo M...
Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on August 14th 2025, it had received a payment of $70,0...
Guided Therapeutics provides update on U.S. trial for LuViva cervical scan
Guided Therapeutics (GTHP) announced it had enrolled enough patients, approximately 430, to begin closing out its U.S. FDA clinical trial for the LuViva Advanced Cervical Scan. The company is now…
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba...
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on June 27th that it made its first shipment of devices...
Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a purchase order and first paymen...
Guided Therapeutics Receives $100,000 from SMI's Investment Partners to Continue Commercialization Process of LuViva in China
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a $100,000 payment from Shandong ...
Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received full payment from its Indonesian ...
Guided Therapeutics: Data from NMPA clinical study signed off on by all sites
Guided Therapeutics announced that physicians from four prestigious medical centers have completed their review and signed off on the study results for submission to the Chinese National Medical Produ...
Guided Therapeutics' Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that leading physicians from four prestigious medical ...
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that a group of prominent cervical cancer doctors are ...
Guided Therapeutics reports completion of study for Chinese regulatory approval
Guided Therapeutics announced the completion of the clinical trial for marketing and sales approval of the Company’s LuViva Advanced Cervical Scan by the Chinese National Medical Products Administrati...
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- #HPV--Guided Therapeutics, Inc. (OTCQB: GTHP) announced today the completion of the clinical trial for marketing and sales approval of the Company's LuViva Ad...
Guided Therapeutics provides update on start of clinical trial
Guided Therapeutics provided an update regarding the start of its pivotal clinical trial. The results of this clinical study will be used to support the Company’s application for U.S. FDA…